Skip to main content
Benjamin Ebert, MD, Oncology, Boston, MA

Benjamin Levine Ebert MD

Hematologic Oncology


President and CEO, Dana-Farber Cancer Institute; Richard and Susan Smith Professor of Medicine, Harvard Medical School

Join to View Full Profile
  • 450 Brookline Avenue, Dana 1610ADana-Farber Cancer InstituteBoston, MA 02115

  • Phone+1 617-632-1902

Dr. Ebert is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2001 - 2005
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1999 - 2001
  • Harvard Medical School
    Harvard Medical SchoolClass of 1999

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2004 - 2025

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2011

Publications & Presentations

PubMed

Journal Articles

  • The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk Factor  
    Robert Sidlow, Amy E Lin, David P Steensma, Benjamin L Ebert, JAMA Cardiology
  • Defining the Human C2H2 Zinc Finger Degrome Targeted by Thalidomide Analogs Through CRBN  
    Benjamin Ebert, MD, Science Magazine
  • CrbnI391V Is Sufficient to Confer in Vivo Sensitivity to Thalidomide and Its Derivatives in Mice  
    Benjamin L Ebert, Emma C Fink, Blood
  • Join now to see all

Abstracts/Posters

  • Deconstructing the Clonal Advantage and Clonal Stability of 5q- Candidate Genes in Del(5q) MDS on a Single Cell Level
    Benjamin L. Ebert, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • High Burden of Clonal Hematopoiesis in First Responders Exposed to the World Trade Center Disaster
    Benjamin L. Ebert, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • TP53 State Dictates Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes
    Benjamin L. Ebert, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • When You Least Expect It: Clonal Hematopoiesis as an Incidental Finding 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
  • Friday Scientific Workshop on Myeloid Development 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Optimizing Clinical Outcomes in Blood Cancers Through Groundbreaking Translational Research 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Join now to see all

Authored Content

  • The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk FactorMay 2020

Press Mentions

  • New Dana-Farber Cancer Hospital Wins Key State Approval, Despite Mass General Brigham Concerns
    New Dana-Farber Cancer Hospital Wins Key State Approval, Despite Mass General Brigham ConcernsMarch 20th, 2025
  • Dana-Farber OK'd for New Adult Cancer Hospital
    Dana-Farber OK'd for New Adult Cancer HospitalMarch 20th, 2025
  • Kimberly Stegmaier Named as Pediatric Oncology Chair at Dana-Farber
    Kimberly Stegmaier Named as Pediatric Oncology Chair at Dana-FarberFebruary 19th, 2025
  • Join now to see all

Grant Support

  • The role of clonal hematopoiesis in the development and therapy of myeloid malignanciesDANA-FARBER CANCER INST2020–2027
  • Development of Novel Therapeutic Strategies in Human LeukemiasDANA-FARBER CANCER INST1997–2025
  • Functional Genomic Dissection Of Refractory AnemiaNational Heart, Lung, And Blood Institute2010–2011
  • Novel Treatment Strategies For Sickle Cell DiseaseNational Center For Research Resources2010–2011
  • Identification Of Functional Tumor-Stromal Interactions In The Bone MarrowNational Cancer Institute2009–2010
  • Functional Dissection Of Erythroid DifferentiationNational Heart, Lung, And Blood Institute2008–2009
  • Functional Genomic Dissection Of Refractory AnemiaNational Heart, Lung, And Blood Institute2008
  • Functional Dissection Of Erythroid DifferentiationNational Heart, Lung, And Blood Institute2005–2007
  • High Throughput Screen For Regulators Of Globin Gene Ex*National Human Genome Research Institute2006
  • High Throughput Screen For Regulators Of GlobinNational Human Genome Research Institute2005

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: